Holen Sie sich die Stockscreener-App
5.40
4.05%
0.21
Vorhandelsmarkt:
5.39
-0.01
-0.19%
Schlusskurs vom Vortag:
$5.19
Offen:
$5.21
24-Stunden-Volumen:
906.19K
Relative Volume:
0.72
Marktkapitalisierung:
$308.06M
Einnahmen:
$5.82M
Nettoeinkommen (Verlust:
$71.18M
KGV:
5.4152
EPS:
0.9972
Netto-Cashflow:
$-84.30M
1W Leistung:
+10.88%
1M Leistung:
+13.45%
6M Leistung:
-2.35%
1J Leistung:
+9.76%
1-Tages-Spanne:
$5.145
$5.445
1-Wochen-Bereich:
$4.81
$5.445
52-Wochen-Spanne:
$4.00
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
Abeona Therapeutics Inc
Sektor
Branche
Telefon
646-813-4701
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.40 | 296.08M | 5.82M | 71.18M | -84.30M | 0.9972 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-30 | Eingeleitet | Stifel | Buy |
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2018-10-12 | Eingeleitet | Mizuho | Buy |
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-11-08 | Eingeleitet | SunTrust | Buy |
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Eingeleitet | Citigroup | Buy |
| 2017-10-05 | Bestätigt | Maxim Group | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-18 | Bestätigt | Maxim Group | Buy |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2017-01-06 | Eingeleitet | Jefferies | Buy |
| 2016-09-29 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
(ABEO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2025 earnings call transcript - MSN
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
JPMorgan Chase Trims Stake in Abeona Therapeutics - National Today
Abeona Therapeutics Stock Price Crosses 50-Day Moving Average - National Today
JPMorgan Chase & Co. Trims Position in Abeona Therapeutics Inc. $ABEO - MarketBeat
Aberdeen Group Invests $3.25M in Abeona Therapeutics - National Today
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
ABEO Should I Buy - Intellectia AI
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair - The Globe and Mail
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors - Sahm
Abeona Therapeutics names Keith Goldan to board of directors By Investing.com - Investing.com Canada
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo Finance UK
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Abeona Therapeutics Announces Appointment of Keith A. Goldan to its Board of Directors - Bitget
Abeona Therapeutics Appoints Keith A. Goldan to Board - National Today
Abeona Therapeutics Appoints Keith A. Goldan to Board of Directors and Audit Committee to Support Commercial Growth - Minichart
[Form 4] ABEONA THERAPEUTICS INC. Insider Trading Activity - Stock Titan
Abeona Therapeutics (ABEO) director Form 3 lists no stock trades - Stock Titan
Keith A. Goldan appointed to Abeona Therapeutics' board, named Audit Committee Chair - TradingView — Track All Markets
Keith Goldan joins Abeona Therapeutics (ABEO) board as independent audit chair - Stock Titan
Biotech Abeona taps veteran CFO Keith Goldan to oversee audits - Stock Titan
Abeona Therapeutics (ABEO) — 3.01M shares disclosed by Funicular/Cable Car (5.3%) - Stock Titan
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Panic Selling: Should I set a stop loss on Abeona Therapeutics Inc2026 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - Sahm
ABEO PE Ratio & Valuation, Is ABEO Overvalued - Intellectia AI
New York hospital joins Abeona network for blistering skin therapy - Stock Titan
ABEO Technical Analysis & Stock Price Forecast - Intellectia AI
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock By Investing.com - Investing.com Australia
Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona The - GuruFocus
Abeona Therapeutics CEO Seshadri Vishwas sells $131k in stock - Investing.com
Abeona (ABEO) CEO sells 29,985 shares under Rule 10b5-1 plan - stocktitan.net
ABEO (NASDAQ: ABEO) Form 144: 29,985 restricted shares proposed sale - Stock Titan
Daniel Kaufman files Schedule 13G — Abeona (NASDAQ: ABEO) 5.16% stake - Stock Titan
Vanguard disaggregates holdings; ABEO ownership shown as 0 (ABEO) - stocktitan.net
Meme Stocks: Does Abeona Therapeutics Inc have strong EBITDA margins2026 Earnings Surprises & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings - MarketBeat
Oppenheimer Maintains Outperform on Abeona Therapeutics (ABEO) PT $22 March 2026 - Meyka
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules - The Globe and Mail
Abeona Therapeutics Adopts Third Amended and Restated Bylaws Effective March 16, 2026 - Minichart
Form 8K Abeona Therapeutics Inc For: 20 March By Investing.com - Investing.com Australia
Form 8K Abeona Therapeutics Inc For: 20 March - Investing.com
Abeona (NASDAQ: ABEO) tightens bylaws on meetings and director nominations - Stock Titan
Abeona Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Abeona Therapeutics Earnings Notes - Trefis
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):